structure catalytic domain human phosphodiesterase bound drug molecules 
phosphodiesterases pdes superfamily enzymes degrade intracellular second messengers cyclic amp cyclic gmp1- essential regulators cyclic nucleotide signalling diverse physiological functions pdes drug targets treatment various diseases including heart failure depression asthma inflammation erectile dysfunction4- pde gene families cgmp-specific pde5 carries principal cgmp-hydrolysing activity human corpus cavernosum tissue well known target sildenafil citrate viagra similar drugs treatment erectile dysfunction despite pressing need develop selective pde inhibitors therapeutic drugs camp-specific pde4 structures currently available89 present three-dimensional structures catalytic domain residues - human pde5 complexed three drug molecules sildenafil tadalafil cialis vardenafil levitra structures will provide opportunities design potent selective pde inhibitors improved pharmacological profiles 
